Parkwalk EIS Funds (IP Group)

Parkwalk Advisors, a wholly-owned subsidiary of IP Group acquired in 2017, is the UK's largest growth EIS (Enterprise Investment Scheme) fund manager with £557m in third-party AUM as of FY2025. It backs world-changing deeptech companies emerging from UK universities across DeepTech (AI, quantum, hardware), HealthTech (digital health, life sciences), and CleanTech (AgTech, future mobility). Named funds include: Opportunities EIS Fund (open, early-stage, Series A–C across Quantum Computing, AI, MedTech, Life Sciences, CleanTech); University of Cambridge Enterprise Funds; University of Oxford Innovation Funds; Imperial College Enterprise Funds; University of Bristol Enterprise Funds; Northern Universities Venture Fund (Leeds, Liverpool, Manchester, Sheffield; co-launched 2025 with Northern Gritstone). Knowledge Intensive EIS Fund V is closed. All funds are equity vehicles — founders pitch via the 'Seeking funding?' form on parkwalk.vc or through their university's tech-transfer office.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.